Orbimed Advisors LLC, 10% Owner at Passage BIO, Inc. (PASG), sold 796,914 shares at $0.35 ($268K) on 2025-06-24, disclosed to the SEC on 2025-06-26.
Open-market sale of $268k PASG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.35 | 231,600 | $81K | 30.3% |
| 2 | $0.33 | 138,800 | $46K | 17.1% |
| 3 | $0.33 | 213,257 | $70K | 26.3% |
| 4 | $0.33 | 213,257 | $70K | 26.3% |
| Total | $0.34 avg | 796,914 | $268K | 100% |
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |